If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
UROLOGY
ISSN 2053-4213 Vol 5.1 • May 2017 • europeanmedical-journal.com
INSIDE
Review of
EAU 2017
London, UK
CONTENTS
EDITORIAL BOARD...................................................................................................................................... 4
CONGRESS REVIEW..................................................................................................................................... 12
• Review of the 32nd Annual European Association of Urology (EAU) Congress,
held in London, UK, 24th–28th March 2017
INTERVIEWS WITH EMJ UROLOGY EDITORIAL BOARD.................................................................... 25
SYMPOSIUM REVIEW
• NOCTURIA: WHAT DO WE NEED TO KNOW IN 2017? IDENTIFYING THE CAUSE AND
TAILORING THE TREATMENT.................................................
UROLOGY ISSN 2053-4213
CONTENTS EDITORIAL BOARD.......................
UROLOGY • INCIDENTALLY DETECTED RENAL ARTERIO
EDITORIAL BOARD EDITOR-IN-CHIEF Dr Abdullah Erd
UROLOGY AIMS AND SCOPE • The European Med
UROLOGY 5.1 MAY 2017 Director Spencer Gore Proj
Welcome Greetings and a very warm welcome to t
Instillation therapies for bladder cancer have a
Foreword Dr Abdullah Erdem Canda
European Medical Journal 2.1 2017
FEATURE Climate Change: What Can Doctors Do? •
12 UROLOGY • May 2017
ONGRE EX 24TH–28TH MARCH 2017 Welcome to th
UROLOGY • May 2017
Congress Highlights Biosensor Chips
Although it is early days, the team are hopeful t
Test to Predict Those at Greatest Prostate Cancer
commonly with hormonal treatments alone witho
The researchers from the University of
Although a condition such as nocturia may seem t
Researchers from the Maastricht University Me
We are not saying that everyone should change fro
Stem cells were taken from abdominal fat cells vi
Protect your investment. Maximise your time. With
Abdullah Erdem Canda Professor of Urology, Depar
Medical students and our residents take great int
able to learn a lot. In addition, they can ask ma
and novel-test screening or guidance is far from
Q: Throughout your life, you have achieved a grea
at the Association. These guidelines have b
to provide us with the focus for achieving one of
NOCTURIA: WHAT DO WE NEED TO KNOW IN 2017?
Introduction The symposium involved three debates
Fatigue due to nocturia results in poor concentra
Nocturnal polyuria
0 -0.2 -0.4 -0.6 -0.8 -1.0 -1.2 -1.4 Adju
If there are no major changes in the pati
Please click on the Figure / Table text throughou
EAU 2017 In conclusion, our data underscore the
Abstract Reviews cell architecture by immunofluor
EAU 2017 of visiting a doctor 12 hours from the
Abstract Reviews serosal injury in 3 patients, 1
EAU 2017 506 (7.3%) patients with E. faecalis (3
Abstract Reviews quality of life (QoL).2 Inadequ
EAU 2017 discussion 632.
Abstract Reviews standard deviation (SD) age (66
EAU 2017 in the limbs and spreads, leading to de
Abstract Reviews CONCLUSION LUTS are more freque
EAU 2017 differences between the groups. There w
Abstract Reviews Supra PCNL should be attempted
EAU 2017 REDO URETHROPLASTY AFTER UNSUCCESSF
Abstract Reviews VALIDATION OF TUMOUR NECROSIS F
EAU 2017 DETRUSOR BIOENGINEERING USING COMPRESSE
Abstract Reviews CONCLUSION In summary, our r
EAU 2017 water displacement/overflow method. The
Abstract Reviews MATERIAL AND METHODS We carried
EAU 2017 2. Cek M et al. Healthcare-associated
Abstract Reviews and androgen modulating agents
EAU 2017 According to the European Association o
Abstract Reviews J Urol. 2014;191(4):1009-13.
EAU 2017 Retrograde urethrography demonstrat
Abstract Reviews renal) undergoing radical surge
Watch our exclusive videos from the 32nd EAU
EDITOR’S PICK Although a rare condit
GENETIC PREDISPOSITION Inherited The current unde
CLINICAL PRESENTATION Clinical presentation of A
preferred for assessment of vascular invasio
is essential to rule out invasion of adjacent org
recurrence.13 CyberKnife® treatment, a stereotact
adrenocortical carcinoma: a prospective compariso
INCIDENTALLY DETECTED RENAL
A B Figure 2: A) Computed tomography angiograph
the angiography room for endovascular treatment (
Table 1: Cases of asymptomatic renal arteriovenou
overcome clinical diagnostic limits and help them
NEGATIVE BIOPSIES WITH RISING PRO
traditionally been detected by randomly sampling
of PSA are enzymatically inactive and inclu
Table 2: Tissue markers of prostate cancer. Tissu
Results to date suggest that this new tissue-base
T2-weighted imaging is used to delineate prostate
8. Eggener SE et al. Empiric antibiotics for an e
MANAGEMENT OF ANTERIOR URETHRAL STRICTURES
In developed countries, these strictures account
bacteraemia, false passage creation, meat
material, stricture recurrence has been reported.
In the past, urologists believed in treating uret
Tissue engineered cell-seeded grafts may be ideal
beneficiaries: underuse of urethroplasty? Urol. 20
urethrotomy: Phase II clinical trial. Int J Urol.
RECENT ADVANCES IN THE PHARMACOTHERAPY
parasympathetic, sympathetic, and motor output in
much better in patient satisfaction rates and IEL
Table 1: Medical treatment options for premature
Among these drugs, silodosin is associated with h
generator for ejaculation. Int J Impot Res. 2005;
controlled study. Am J Psychiatry. 1994; 151(9):1
RENAL STONES: A CLINICAL REVIEW *Ramesh Agga
Table 2: Factors causing increased risk of renal
chronic obstruction. Bleeding may be chronic and
(e.g. primary hyperparathyroidism) are excluded,
tract symptoms due to prostatic enlargement.
14. Curhan G. Imaging in the emergency department
Buyer’s Guide • A.M.I. AGENCY FOR MEDICAL
• M.A.S. MEDICAL SRL • MAVIG GMBH • MDXHEALTH,
SUBSCRIBE TO RECEIVE THE LATEST PUBLICATIONS, NEW